Visivasnc/iStock via Getty Images Revance Therapeutics ( NASDAQ: RVNC ) fell 8% as the deadline for Crown Laboratories tender offer is set to expire on Friday. Crown Labs has extended the tender offer deadline a few times, most recently a week ago, as Revance ( RVNC ) continues talks.
Back to Health Page
